- Title
- Re: Kucharz EJ, Kovalenko V, Szanto S, etal. A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes. Curr Med Res Opin 2016;32:997-1004
- Creators - without role
- Jean-Yves Reginster - University of LiègeCyrus Cooper - MRC Lifecourse Epidemiology UnitOlivier Bruyere - NIHR Oxford Musculoskeletal Biomedical Research Centre
- Publication Details
- Current medical research and opinion, Vol.32(11), pp.1771-1772
- Publisher
- Taylor & Francis
- Number of pages
- 2
- Grant note
- MC_U147585824; MC_UP_A620_1014; MC_U147585819; MC_U147585827; MC_UU_12011/1; G0400491 / Medical Research Council; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); European Commission U1475000001 / Medical Research Council; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); European Commission MC_U147585827 / MRC; UK Research & Innovation (UKRI); Medical Research Council UK (MRC) NF-SI-0508-10082 / National Institute for Health Research; National Institute for Health Research (NIHR)
- Identifiers
- 9948692808331
- Academic Unit
- King Saud University
- Language
- English
- Resource Type
- Journal article
Journal article
Re: Kucharz EJ, Kovalenko V, Szanto S, etal. A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes. Curr Med Res Opin 2016;32:997-1004
Current medical research and opinion, Vol.32(11), pp.1771-1772
01/11/2016
PMID: 27649741
Metrics
1 Record Views